Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Acta Neuropathologica

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00401-016-1661-yPMID 28012041PMCID PMC5326583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice.

  2016cited by this paper
• Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.

  2015cited by this paper
• In vivo gastric detection of α‐synuclein inclusions in Parkinson's disease

  2015cited by this paper
• Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies

  2015cited by this paper
• Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury

  2015cited by this paper
• Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies

  2015cited by this paper
• Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

  2014cited by this paper
• No Direct Projection is Observed from the Substantia Nigra to the Dorsal Vagus Complex in the Rat

  2014cited by this paper
• Caudo-rostral brain spreading of α-synuclein through vagal connections

  2013cited by this paper
• α‐Synuclein: The Long Distance Runner

  2013cited by this paper
• Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

  2013cited by this paper
• 100 years of Lewy pathology

  2013cited by this paper
• Exosomal cell-to-cell transmission of alpha synuclein oligomers

  2012cited by this paper
• Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport

  2012cited by this paper
• Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss

  2012cited by this paper
• Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice

  2012cited by this paper
• Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases

  2012cited by this paper
• Analysis of colonic alpha-synuclein pathology in multiple system atrophy.

  2012cited by this paper
• Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  2010cited by this paper
• Versatile, high-resolution anterograde labeling of vagal efferent projections with dextran amines.

  2009cited by this paper
• Imaging individual mRNA molecules using multiple singly labeled probes

  2008cited by this paper
• Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?

  2008cited by this paper
• Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.

  2006cited by this paper
• The fiber composition of the abdominal vagus of the rat

  2004cited by this paper
• Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

  2003cited by this paper
• Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System

  2002cited by this paper
• Topographic inventories of vagal afferents in gastrointestinal muscle

  2000cited by this paper
• A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's disease

  2000cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Simultaneous labeling of vagal innervation of the gut and afferent projections from the visceral forebrain with Dil injected into the dorsal vagal complex in the rat

  1990cited by this paper
• Functional and histological studies of the vagus nerve and its branches to the heart, lungs and abdominal viscera in the cat

  1957cited by this paper

• Interoception in Parkinson's disease: A narrative review and framework for translational research.

  2025cites this paper
• The role of T cells in the treatment of Parkinson’s disease

  2025cites this paper
• Possible linking and treatment between Parkinson’s disease and inflammatory bowel disease: a study of Mendelian randomization based on gut–brain axis

  2025cites this paper
• Parkinson's disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies.

  2025cites this paper
• Intranasal α-Synuclein Induces Progressive Behavioral Impairments in Mice.

  2025cites this paper
• Disrupted Paraventricular Hypothalamic Nucleus Functional Connectivity in Parkinson's Disease With Constipation

  2025cites this paper
• Modulating α-synuclein propagation and decomposition: implications in Parkinson's disease therapy.

  2024cites this paper
• Research Progress on the Relationship between Parkinson's Disease and REM Sleep Behavior Disorder.

  2024cites this paper
• A review on gut microbiota and miRNA crosstalk: implications for Alzheimer’s disease

  2024cites this paper
• Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression

  2024cites this paper
• α‐Synuclein in Parkinson's Disease: From Bench to Bedside

  2024cites this paper
• Non-transgenic models of Parkinson's disease: the pursuit of a resemblance

  2024cites this paper
• Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis

  2024cites this paper
• The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease

  2024cites this paper
• Intelligent treatment system based on bioinformatics and neuro-immune-digestive tract diseases

  2024cites this paper
• Gastrointestinal dysmotility in rodent models of Parkinson's disease.

  2024cites this paper
• Nigrostriatal 6-hydroxydopamine lesions increase alpha-synuclein levels and permeability in rat colon.

  2023cites this paper
• Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

  2023cites this paper
• Brain-to-gut trafficking of alpha-synuclein by CD11c+ cells in a mouse model of Parkinson’s disease

  2023cites this paper
• The Golgi complex of dopaminergic enteric neurons is fragmented in a hemiparkinsonian rat model

  2023cites this paper
• Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease.

  2023cites this paper
• Rehabilitation for non-motor symptoms for patients with Parkinson's disease from an α-synuclein perspective: a narrative review.

  2023cites this paper
• α-Synuclein seeding activity in duodenum biopsies from Parkinson’s disease patients

  2023cites this paper
• Effects of gut microbiota on neurodegenerative diseases

  2023influential citation
• Neuropathology of incidental Lewy body & prodromal Parkinson’s disease

  2023cites this paper
• Experimental models of gut‐first Parkinson's disease: A systematic review

  2023cites this paper
• The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models

  2023cites this paper
• Disease mechanisms as subtypes: Microbiome.

  2023cites this paper
• The gut microbiome as a factor in the development of Parkinson's disease

  2023cites this paper
• Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson's Disease.

  2023cites this paper
• Neurobiology of Aging

  2023cites this paper
• The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic

  2022cites this paper
• Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management

  2022cites this paper
• Modeling of Neurodegenerative Diseases: ‘Step by Step’ and ‘Network’ Organization of the Complexes of Model Systems

  2022cites this paper
• Overexpression-Induced α-Synuclein Brain Spreading

  2022cites this paper
• Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment

  2022cites this paper
• Clinical application of prion-like seeding in α-synucleinopathies: Early and non-invasive diagnosis and therapeutic development

  2022cites this paper
• LRRK2-G2019S Synergizes with Ageing and Low-Grade Inflammation to Promote Gut and Peripheral Immune Cell Activation that Precede Nigrostriatal Degeneration

  2022cites this paper
• Neuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreading

  2022cites this paper
• Dual Effects: Intrastriatal Injection of α-syn N103/tau N368 Preformed Fibrils Promotes Endogenous α-synuclein Aggregates in the Proximal Colon

  2022cites this paper
• Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism

  2022cites this paper
• Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer’s disease and Parkinson’s disease: a large-scale multi-trait association analysis

  2022cites this paper
• Targeting alpha-synuclein or tau for treating neurodegenerative movement disorders.

  2022cites this paper
• GUT-MICROBIOME-BRAIN AXIS AND ITS INFLUENCE ON PARKINSON'S DISEASE (Review Article)

  2022cites this paper
• To the Gut Microbiome and Beyond: The Brain-First or Body-First Hypothesis in Parkinson’s Disease

  2022cites this paper
• Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management

  2022cites this paper
• “Reframing” dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications

  2022cites this paper
• What Is the Prognostic Significance of Rapid Eye Movement Sleep Without Atonia in a Polysomnogram?

  2022cites this paper
• Brain-gut-microbiota axis in Parkinson's disease: a historical review and future perspective.

  2022cites this paper
• Morbus Parkinson

  2022cites this paper
• Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.

  2022cites this paper
• Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models

  2022cites this paper
• Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

  2021cites this paper
• The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline

  2021cites this paper
• Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?

  2021cites this paper
• Association of Parkinson’s Disease With Microbes and Microbiological Therapy

  2021cites this paper
• Functional roles of the microbiota-gut-brain axis in Alzheimer’s disease: Implications of gut microbiota-targeted therapy

  2021cites this paper
• Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses.

  2021cites this paper
• Animal models of brain-first and body-first Parkinson's disease.

  2021influential citation
• Interactions between the microbiota and enteric nervous system during gut-brain disorders.

  2021cites this paper
• Spreading of alpha-synuclein pathology from the gut to the brain in Parkinson's disease

  2021cites this paper
• Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease

  2021cites this paper
• Potential Roles of Gut Microbiota and Microbial Metabolites in Parkinson's Disease.

  2021cites this paper
• Neuropathological evidence of body-first vs. brain-first Lewy body disease.

  2021cites this paper
• What Substance P might tell us about the Prognosis and Mechanism of Parkinson's Disease?

  2021cites this paper
• What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson’s Disease?

  2021cites this paper
• Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats

  2021cites this paper
• Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation

  2021cites this paper
• Prodromal Parkinson disease subtypes — key to understanding heterogeneity

  2021cites this paper
• Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease

  2021cites this paper
• Periphery and brain, innate and adaptive immunity in Parkinson’s disease

  2021cites this paper
• Parkinson’s Disease: A Prionopathy?

  2021cites this paper
• α-Synuclein–induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms

  2021cites this paper
• Movement of prion‐like α‐synuclein along the gut–brain axis in Parkinson's disease: A potential target of curcumin treatment

  2021cites this paper
• Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.

  2021cites this paper
• Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson’s Disease: Current Understanding and Knowledge Gaps

  2021cites this paper
• Clinical and Pre-Clinical Evidence for Enteric α-Synuclein Involvement in Parkinson's Disease

  2021cites this paper
• Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson’s Disease?

  2021influential citation
• New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota

  2021cites this paper
• Propagated α-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice.

  2020cites this paper
• Nigral overexpression of α‐synuclein in a rat Parkinson’s disease model indicates alterations in the enteric nervous system and the gut microbiome

  2020cites this paper
• La maladie de Parkinson est aussi une maladie du tube digestif

  2020cites this paper
• The progress of gut microbiome research related to brain disorders

  2020influential citation
• Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases

  2020cites this paper
• What Are the Molecular Mechanisms by Which Functional Bacterial Amyloids Influence Amyloid Beta Deposition and Neuroinflammation in Neurodegenerative Disorders?

  2020cites this paper
• Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease

  2020cites this paper
• Selective neuronal vulnerability in Parkinson's disease.

  2020cites this paper
• The gut microbiome in Parkinson's disease: A culprit or a bystander?

  2020cites this paper
• Symbiotic Relationship with Gut Microbiomes and Parkinson Disease

  2020cites this paper
• The Noradrenergic System in Parkinson’s Disease

  2020cites this paper
• Modeling Parkinson’s Disease With the Alpha-Synuclein Protein

  2020cites this paper
• Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.

  2020cites this paper
• Dissecting the Role of Subtypes of Gastrointestinal Vagal Afferents

  2020cites this paper
• α-Synuclein in Parkinson’s Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?

  2020cites this paper
• Parkinson disease and the gut: new insights into pathogenesis and clinical relevance

  2020cites this paper
• Blood Flow as a Route for Bidirectional Propagation of Synucleinopathy in Parkinson's Disease?

  2020cites this paper
• Alpha Synuclein Connects the Gut-Brain Axis in Parkinson’s Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology

  2020cites this paper
• Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson’s Disease

  2020cites this paper
• From the Gut to the Brain and Back: Therapeutic Approaches for the Treatment of Network Dysfunction in Parkinson's Disease

  2020cites this paper
• Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics

  2020cites this paper